Yinfeng Yang

Dr. Yinfeng Yang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
SQShanna Qian
Shanna Qian
ZWZhong Wei
Zhong Wei
WYWanting Yang
Wanting Yang
JHJinling Huang
Jinling Huang
YYYinfeng Yang
Yinfeng Yang
JWJinghui Wang
Jinghui Wang
Apoptosis, as a very important biological process, is a response to developmental cues or cellular stress. Impaired apoptosis plays a central role in the development of cancer and also reduces the efficacy of traditional cytotoxic therapies. Members of the B-cell lymphoma 2 (BCL-2) protein family have pro- or anti-apoptotic activities and have been studied intensively over the past decade for their importance in regulating apoptosis, tumorigenesis, and cellular responses to anticancer therapy. Since the inflammatory response induced by apoptosis-induced cell death is very small, at present, the development of anticancer drugs targeting apoptosis has attracted more and more attention. Consequently, the focus of this review is to summarize the current research on the role of BCL-2 family proteins in regulating apoptosis and the development of drugs targeting BCL-2 anti-apoptotic proteins. Additionally, the mechanism of BCL-2 family proteins in regulating apoptosis was also explored. All the findings indicate the potential of BCL-2 family proteins in the therapy of cancer.

16 May 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
PYPeizheng Yang
Peizheng Yang
WYWanting Yang
Wanting Yang
ZWZhong Wei
Zhong Wei
YLYan Li
Yan Li
YYYinfeng Yang
Yinfeng Yang
JWJinghui Wang
Jinghui Wang
Gastric cancer (GC) is a fatal illness, and its mortality rate is very high all over the world. At present, it is a serious health problem for any country. It is a multifactorial disease due to the rising drug resistance and the increasing global cancer burden, the treatment of GC still faces many obstacles and problems. In recent years, research on GC is being carried out continuously, and we hope to address the new targets of GC treatment through this review. At the same time, we also hope to discover new ways to fight GC and create more gospel for clinical patients. First, we discuss the descriptive tumor microenvironment (TME), N6-methyladenosine (m6A), pyroptosis, autophagy, ferroptosis, and cuproptosis. Finally, we expounded on the new or potential targets of GC treatment.

28 October 2024 in Journal of Advanced Research
Verified
Journal Article
Open access
XWXiangyu Wang
Xiangyu Wang
JYJianhua Yang
Jianhua Yang
WYWanting Yang
Wanting Yang
HSHaiyang Sheng
Haiyang Sheng
BJBuyun Jia
Buyun Jia
JWJinghui Wang
Jinghui Wang
The protein p53, encoded by the most frequently mutated gene TP53 in human cancers, has diverse functions in tumor suppression. As a best known transcription factor, p53 can regulate various fundamental cellular responses, ranging from the cell-cycle arrest, DNA repair, senescence to the programmed cell death (PCD), which includes autophagy, apoptosis, ferroptosis, cuproptosis, pyroptosis and disulfidoptosis. Accumulating evidence has indicated that the tumor microenvironment (TME), N6-methyladenosine (m6A) modification and diverse PCD are important for the progression, proliferation and metastases of cancers. This paper aims to systematically and comprehensively summarize the multiple roles of p53 in the development of cancers from the regulation of TME, m6A Modification and diverse PCD. TME, a crucial local homeostasis environment, influences every step of tumorigenesis and metastasis. m6A, the most prevalent and abundant endogenous modification in eukaryotic RNAs, plays an essential role in various biological processes, containing the progression of cancers. Additionally, PCD is an evolutionarily conserved mechanism of cell suicide and a common process in living organisms. Some forms of PCD contribute to the occurrence and development of cancer. However, the complex roles of p53 within the TME, m6A modification and diverse PCD mechanisms are still not completely understood. Presently, the function roles of p53 including the wild-type and mutant p53 in different context are summarized. Additionally, the interaction between the cancer immunity, cancer cell death and RNA m6A methylation and the p53 regulation during the development and progress of cancers were discussed. Moreover, the key molecular mechanisms by which p53 participates in the regulation of TME, m6A and diverse PCD are also explored. All the findings will facilitate the development of novel therapeutic approaches.

Verified
Journal Article
Open access
PDF file
JZJingxiao Zhang
Jingxiao Zhang
YLYan Li
Yan Li
SCSu-Shing Chen
Su-Shing Chen
LZLilei Zhang
Lilei Zhang
JWJinghui Wang
Jinghui Wang
LYLing Yang
Ling Yang
Inflammation is a hallmark of many diseases like diabetes, cancers, atherosclerosis and arthritis. Thus, lots of concerns have been raised toward developing novel anti-inflammatory agents. Many alternative herbal medicines possess excellent anti-inflammatory properties, yet their precise mechanisms of action are yet to be elucidated. Here, a novel systems pharmacology approach based on a large number of chemical, biological and pharmacological data was developed and exemplified by a probe herb Folium Eriobotryae, a widely used clinical anti-inflammatory botanic drug. The results show that 11 ingredients of this herb with favorable pharmacokinetic properties are predicted as active compounds for anti-inflammatory treatment. In addition, via systematic network analyses, their targets are identified to be 43 inflammation-associated proteins including especially COX2, ALOX5, PPARG, TNF and RELA that are mainly involved in the mitogen-activated protein kinase (MAPK) signaling pathway, the rheumatoid arthritis pathway and NF-κB signaling pathway. All these demonstrate that the integrated systems pharmacology method provides not only an effective tool to illustrate the anti-inflammatory mechanisms of herbs, but also a new systems-based approach for drug discovery from, but not limited to, herbs, especially when combined with further experimental validations.

1 January 2024 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
QLQiwei Liu
Qiwei Liu
JWJinghui Wang
Jinghui Wang
ZGZongyun Gu
Zongyun Gu
TOTing Ouyang
Ting Ouyang
HGHonglei Gao
Honglei Gao
YYYinfeng Yang
Yinfeng Yang

3 June 2024 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
LSLiping Sun
Liping Sun
JHJili Hu
Jili Hu
YYYinfeng Yang
Yinfeng Yang
YWYongkang Wang
Yongkang Wang
ZWZijian Wang
Zijian Wang
HKHongxing Kan
Hongxing Kan